(Q34571867)

3 August 2017

1 reference

title

Management of soft-tissue sarcomas: an overview and update (English)

1 reference

3 August 2017

S Singer

1

1 reference

3 August 2017

G D Demetri

series ordinal

2

1 reference

3 August 2017

E H Baldini

series ordinal

3

1 reference

3 August 2017

C D Fletcher

series ordinal

4

1 reference

3 August 2017

publication date

1 October 2000

1 reference

Lancet Oncology Commission

3 August 2017

published in

1 reference

3 August 2017

volume

1

1 reference

3 August 2017

page(s)

75-85

1 reference

Variable management of soft tissue sarcoma: regional audit with implications for specialist care

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900016-4

7 January 2021

The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900016-4

7 January 2021

Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900016-4

7 January 2021

Adjuvant chemotherapy for patients with high-grade soft-tissue sarcomas of the extremity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900016-4

7 January 2021

Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900016-4

7 January 2021

Association of local recurrence with subsequent survival in extremity soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900016-4

7 January 2021

The biological significance of failure at the primary site on ultimate survival in soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900016-4

7 January 2021

Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900016-4

7 January 2021

Limb-sparing surgery without radiotherapy based on anatomic location of soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900016-4

7 January 2021

Long-term outcomes after function-sparing surgery without radiotherapy for soft tissue sarcoma of the extremities and trunk

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900016-4

7 January 2021

Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900016-4

7 January 2021

Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900016-4

7 January 2021

Diagnosis and management of retroperitoneal soft-tissue sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900016-4

7 January 2021

Prognostic factors in primary retroperitoneal soft-tissue sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900016-4

7 January 2021

Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900016-4

7 January 2021

Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900016-4

7 January 2021

Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900016-4

7 January 2021

Treatment of the patient with stage M0 soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900016-4

7 January 2021

Soft tissue sarcoma. Integration of brachytherapy, resection, and external irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900016-4

7 January 2021

Prognostic factors predictive of survival and local recurrence for extremity soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900016-4

7 January 2021

Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900016-4

7 January 2021

A multivariate analysis of the prognosis after surgical treatment of malignant soft-tissue tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900016-4

7 January 2021

Oncological outcomes of operative treatment of subcutaneous soft-tissue sarcomas of the extremities

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900016-4

7 January 2021

Prognostic factors in 227 patients with malignant fibrous histiocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900016-4

7 January 2021

Morbidity of adjuvant brachytherapy in soft tissue sarcoma of the extremity and superficial trunk

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900016-4

7 January 2021

Limb salvage in soft tissue sarcomas involving neurovascular structures using combined surgical resection and brachytherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900016-4

7 January 2021

Intraoperative radiotherapy in retroperitoneal sarcomas. Final results of a prospective, randomized, clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900016-4

7 January 2021

High-dose-rate intraoperative radiation therapy (HDR-IORT) for retroperitoneal sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900016-4

7 January 2021

Ewing's sarcoma of soft tissues in childhood: a report from the Intergroup Rhabdomyosarcoma Study, 1972 to 1991

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900016-4

7 January 2021

The Third Intergroup Rhabdomyosarcoma Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900016-4

7 January 2021

Results of single-agent and combination chemotherapy for advanced soft tissue sarcomas. Implications for decision making in the clinic.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900016-4

7 January 2021

High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies--dose-response and schedule dependence

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900016-4

7 January 2021

Should patients with advanced sarcomas be treated with chemotherapy?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900016-4

7 January 2021

An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900016-4

7 January 2021

Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900016-4

7 January 2021

Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900016-4

7 January 2021

Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens--a European Organization for Research and Treatment of Cancer Soft Tissue and

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900016-4

7 January 2021

Influence of biologic factors and anatomic site in completely resected liposarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900016-4

7 January 2021

Surgical margins, local recurrence and metastasis in soft tissue sarcomas: 559 surgically-treated patients from the Scandinavian Sarcoma Group Register.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900016-4

7 January 2021

10.1016/S1470-2045(00)00016-4

Identifiers

DOI

1 reference

3 August 2017

1 reference